CDD for Biologics
Hanson Wade
info@hansonwade.com
+1 415 735 3289
Returning 13-15 November, the 3rd Annual meeting remains the only industry-centric meeting solely dedicated to exploring the in silico prediction, design, and modelling of biotherapeutics.
Across 3 days of intensive presentations, discussion and debate, the event will again unite computational leaders from pioneering pharmaceutical organizations, academic and software development labs.
This year, topics will span the in silico prediction, design, and modelling of biologics. With a greater focus beyond applications limited to MAb’s the agenda will showcase advances with computational tools for vaccine, enzyme, multispecific and linker-based biologics and highlight the iterative experimental processes.
The CDD for Biologics Summit remains solely dedicated to exploring the power of in silico tools to de-risk biologics drug development. Our mission has been, and remains, to provide a forum that unite stakeholders from across pharma, academia and software providers along with the end users in computational biology, structural biology and bioinformatics to define current capabilities, and realise how these tools can be further adapted to add immediate value to biologics pipelines.
Focused principally on design and developability of antibodies, this year’s case studies will reveal the applications of these methods to other biotherapeutic modalities, from early drug discovery through to late preclinical development.
Discussion will centre around means to overcome data availability, model validation and standardization issues.
Join us to identify market trends, enhance cost-effectiveness, shorten biologics development timelines and accelerate program development with insights from our industry leading speaker faculty.
Visit cdd-biologics.com to find out more and download the full event brochure here: cdd-biologics.com/agenda/full-event-guide/
